Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Hepatitis C Virus Prevalence in Egyptian Americans in Southern California.

Saab S, Viramontes MR, Chalifoux SL, Craw CJ, Ramirez SD, Bau SN, Arevalo DG, Saab EG, Saab CE, Craw CS, Estafanous A, Messiah R, Messiah W, El Kabany M.

J Clin Gastroenterol. 2017 Jun 14. doi: 10.1097/MCG.0000000000000858. [Epub ahead of print]

PMID:
28617761
2.

Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States.

Saab S, Jimenez M, Fong T, Wu C, Bau S, Jamal Z, Grotts J, Elashoff D.

J Clin Transl Hepatol. 2016 Jun 28;4(2):76-82. doi: 10.14218/JCTH.2016.00011. Epub 2016 Jun 15.

3.

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use.

Saab S, Rheem J, Jimenez M, Bau S, Choi G, Durazo F, El Kabany M, Han S, Farid A, Jamal N, Grotts J, Elashoff D, Busuttil RW.

J Clin Transl Hepatol. 2016 Mar 28;4(1):32-8. doi: 10.14218/JCTH.2016.00001. Epub 2016 Mar 15.

4.

Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis.

Saab S, Jimenez M, Bau S, Goo T, Zhao D, Durazo F, Han S, El Kabany M, Kaldas F, Tong MJ, Busuttil RW.

Clin Transplant. 2015 Sep;29(9):813-9. doi: 10.1111/ctr.12584. Epub 2015 Aug 21.

PMID:
26147216
5.

Guidelines for Using Movement Science to Inform Biodiversity Policy.

Barton PS, Lentini PE, Alacs E, Bau S, Buckley YM, Burns EL, Driscoll DA, Guja LK, Kujala H, Lahoz-Monfort JJ, Mortelliti A, Nathan R, Rowe R, Smith AL.

Environ Manage. 2015 Oct;56(4):791-801. doi: 10.1007/s00267-015-0570-5. Epub 2015 Jun 23. Review.

PMID:
26099570
6.

Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients.

Saab S, Greenberg A, Li E, Bau SN, Durazo F, El-Kabany M, Han S, Busuttil RW.

Liver Int. 2015 Nov;35(11):2442-7. doi: 10.1111/liv.12856. Epub 2015 May 12.

PMID:
25913321
7.

A laboratory study of the performance of the handheld diffusion size classifier (DiSCmini) for various aerosols in the 15-400 nm range.

Bau S, Zimmermann B, Payet R, Witschger O.

Environ Sci Process Impacts. 2015 Feb;17(2):261-9. doi: 10.1039/c4em00491d.

PMID:
25366997
8.

Boceprevir in liver transplant recipients.

Saab S, Manne V, Bau S, Reynolds JA, Allen R, Goldstein L, Durazo F, El-Kabany M, Han S, Busuttil RW.

Liver Int. 2015 Jan;35(1):192-7. doi: 10.1111/liv.12548. Epub 2014 Apr 11.

PMID:
24673728
9.

Viral breakthrough is associated with resistance using direct acting agents in patients treated for chronic hepatitis C infection.

Zhou K, Ferguson J, Bau S, Saab S.

J Clin Gastroenterol. 2014 Jul;48(6):548-52. doi: 10.1097/MCG.0b013e3182a8824c.

PMID:
24045279
10.

Lifestyle change and mobility in obese adults with type 2 diabetes.

Rejeski WJ, Ip EH, Bertoni AG, Bray GA, Evans G, Gregg EW, Zhang Q; Look AHEAD Research Group.

N Engl J Med. 2012 Mar 29;366(13):1209-17. doi: 10.1056/NEJMoa1110294.

11.

Evaluation of the diffusion size classifier (meDiSC) for the real-time measurement of particle size and number concentration of nanoaerosols in the range 20-700 nm.

Bau S, Jacoby J, Witschger O.

J Environ Monit. 2012 Mar;14(3):1014-23. doi: 10.1039/c2em10619a. Epub 2012 Feb 14.

PMID:
22334128
12.

Four-year weight losses in the Look AHEAD study: factors associated with long-term success.

Wadden TA, Neiberg RH, Wing RR, Clark JM, Delahanty LM, Hill JO, Krakoff J, Otto A, Ryan DH, Vitolins MZ; Look AHEAD Research Group.

Obesity (Silver Spring). 2011 Oct;19(10):1987-98. doi: 10.1038/oby.2011.230. Epub 2011 Jul 21.

13.
14.

Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.

Summerer D, Schracke N, Wu H, Cheng Y, Bau S, Stähler CF, Stähler PF, Beier M.

Genomics. 2010 Apr;95(4):241-6. doi: 10.1016/j.ygeno.2010.01.006. Epub 2010 Feb 6.

15.

Targeted next-generation sequencing by specific capture of multiple genomic loci using low-volume microfluidic DNA arrays.

Bau S, Schracke N, Kränzle M, Wu H, Stähler PF, Hoheisel JD, Beier M, Summerer D.

Anal Bioanal Chem. 2009 Jan;393(1):171-5. doi: 10.1007/s00216-008-2460-7. Epub 2008 Oct 29.

PMID:
18958448
16.
17.

Co-option of a default secretory pathway for plant immune responses.

Kwon C, Neu C, Pajonk S, Yun HS, Lipka U, Humphry M, Bau S, Straus M, Kwaaitaal M, Rampelt H, El Kasmi F, Jürgens G, Parker J, Panstruga R, Lipka V, Schulze-Lefert P.

Nature. 2008 Feb 14;451(7180):835-40. doi: 10.1038/nature06545.

PMID:
18273019
18.

Clinical usefulness of 3-dimensional sonography and power Doppler angiography for diagnosis of endometrial carcinoma.

Mercé LT, Alcázar JL, López C, Iglesias E, Bau S, Alvarez de los Heros J, Bajo JM.

J Ultrasound Med. 2007 Oct;26(10):1279-87.

PMID:
17901132
19.
20.

Prediction of ovarian response and IVF/ICSI outcome by three-dimensional ultrasonography and power Doppler angiography.

Mercé LT, Barco MJ, Bau S, Troyano JM.

Eur J Obstet Gynecol Reprod Biol. 2007 May;132(1):93-100. Epub 2007 Feb 27.

PMID:
17329008

Supplemental Content

Loading ...
Support Center